Sarpogrelate HCL 300mg

DRUG2 trials

Sponsors

Daewoong Pharmaceutical Co. LTD.

Conditions

Healthy

Phase 1

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions

Daewoong Pharmaceutical Co. LTD.Healthy

Start: 2019-03-04End: 2019-05-13Updated: 2019-05-14

Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

CompletedNCT03947489

Daewoong Pharmaceutical Co. LTD.Healthy

Start: 2019-03-04End: 2019-05-06Updated: 2019-05-14